Pharma company website design that serves doctors, distributors and regulators without mixing them up

What is pharma company website design, and who is the site really for?

Pharma company website design is the planning and build of a manufacturer's or marketer's website so that each outside group, from prescribers to regulators, finds what it needs without seeing what it should not. That second half is what separates it from ordinary corporate web design.

A formulations maker in Baddi and an API producer in Hyderabad both need a website, but neither is selling to the person scrolling on a phone at a bus stop. The real visitors are narrower: a physician checking a composition, a distributor comparing principal companies, a purchase officer at a hospital, an importer who wants a dossier, a bank or investor reading the annual report, and occasionally an inspector or journalist. Each one arrives with a question and leaves within a minute if the answer is buried.

So the first job in pharma company website design is not the home page banner. It is a map of audiences against content, with a decision next to each item: public, gated for healthcare professionals, or shared only after an enquiry. Once that map exists, navigation, page templates and forms more or less design themselves.

• Public: company profile, plant and quality overview, therapy areas, product names with generic names, careers, contact.
• Healthcare professionals: prescribing information, dosage, contraindications, product monographs, CME listings.
• Trade: distributor terms, stockist onboarding, export capability, dossier availability.
• Investors and public record: results, policies, board, CSR.

If your business is a franchise-led marketer rather than a manufacturer, the audience map changes; see websites for PCD pharma companies.

How do you keep doctors, distributors and the public apart on one pharma website?

Use three entry paths from the home page, each with its own navigation and forms, and put a declaration gate in front of prescriber-level detail. Keeping the paths apart is cheaper than building three separate websites and far easier to keep accurate.

In practice the header carries three clear links, something like “For healthcare professionals”, “Distributors and export” and “Investors”, while the main menu handles the public story. A doctor who clicks the first link sees a short interstitial asking them to confirm they are a registered medical practitioner or pharmacist. That confirmation is stored in a cookie for the session, and only then do dosage tables and product monographs load. Some companies go further with a login tied to a registration number; that is a heavier build, and we will tell you honestly whether your volume of doctor traffic justifies it.

Distributors never need the prescriber content. Their path leads to territory information, onboarding steps and a form that asks the questions your sales head would ask on the phone. Investors get a plain, document-heavy section, laid out for a company secretary to update.

Product and molecule catalogue: the core of pharma company website design

Build the catalogue as structured data, one record per product, and generate pages and filters from it; never type products into free-form pages. This single decision decides whether the site stays accurate when you add fifty SKUs next year.

Each record holds the brand name, the generic name and strength of every active ingredient, dosage form, pack size, therapy area, storage conditions and, where you choose to show it, the approval or licence reference. The public product page leads with the generic name next to the brand, a small but useful habit that also matches what UCPMP 2024 asks of prescriber-facing material. Doctors search by molecule, distributors search by brand and pack, importers search by molecule and dosage form, so the filter bar needs all three.

For an API or bulk-drug maker the fields differ: CAS number, grade (IP, BP, USP, EP where you hold them), DMF or CEP availability stated factually, and minimum order quantity. For contract manufacturers the catalogue is often a capability list by dosage form and line capacity, not a brand list.

Up to around 100 product pages fit the static plan from ₹10,000. When a range runs into hundreds of molecule-strength combinations, each with its own URL, the SEO website plan from ₹20,000 is the right size. Chemical suppliers with similar needs can compare notes on our chemical company website design page.

How should a pharma website display WHO-GMP and other certificates?

Show each certificate as a record, not just a scanned image: name, issuing authority, the site or line it covers, the date issued and the valid-until date, with the scan available on click. Buyers and auditors read the scope and dates first, and a certificate that expired last quarter does more harm than no certificate.

Import buyers in particular look for WHO-GMP, the manufacturing licence under the Drugs and Cosmetics framework, compliance with Schedule M, ISO certificates and any foreign regulatory inspections you have passed. We never write that your plant “is approved” by any body unless you give us the document that says so, with its exact wording, and we copy that wording rather than paraphrasing it.

On the build side the certificate wall reads from the same data store as the catalogue, so a certificate can be linked to the products made on that line. A simple admin reminder, a coloured flag in the CMS or an email to your quality head thirty days before a valid-until date, stops stale proof from sitting on the site for months. This is one of the cheapest features in pharma company website design and one of the most useful.

• Certificate name exactly as issued
• Issuing body and certificate number, if you are comfortable publishing it
• Site, block or line covered
• Issue date and valid-until date
• Downloadable scan, watermarked if you prefer
• Date the entry was last checked by your quality team

Distributor and stockist enquiries: forms your sales head will actually use

A distributor form should ask the qualifying questions up front, drug licence number, GST number, district or state, current principal companies and warehouse capacity, and then route the lead to the zonal manager for that territory. A generic “name, email, message” form produces calls your team cannot prioritise.

We usually build the form in two short steps so it does not scare people on a phone: first the basics and territory, then the licence and business details. The submission lands in a Google Sheet or your CRM with the territory already mapped, and a WhatsApp alert reaches the right manager. If you already run a CRM, connecting the website to it avoids retyping.

Larger companies eventually want a logged-in area where appointed distributors see current schemes, download price lists, check order status and raise claims. That is a portal, priced as custom software from ₹60,000, and it often grows into a full distributor management system or a B2B ordering app for field teams. Start with the form; build the portal when the enquiries are coming in.

Export enquiries on a pharma company website: importers, dossiers and registrations

Give export buyers their own section with the countries you already supply, the dosage forms you can make for export, the documents you can share after an NDA, and a form that asks which country and which products they need. Importers compare several Indian suppliers at once, and the one that answers their document questions fastest usually gets the second email.

Useful export content includes a plain list of markets where your products are registered or supplied (only ones you can stand behind), dossier formats you can prepare, private-label or contract manufacturing capability, and packing and labelling options by market. Keep these as structured lists, not paragraphs, because buyers scan.

The enquiry form asks for company name, country, importer licence status, products and quantities, and which documents they want, for example a certificate of pharmaceutical product, a stability summary or a dossier. That tells your export desk whether the lead is a registered importer or a trader testing prices. International buyers also expect the site to load quickly abroad; hosting with a content delivery network and a light page weight matter more here than on the domestic pages. Our website for exporters page and the international SEO guide go deeper on reaching buyers in other countries.

Is promotional content on a pharma company website covered by UCPMP 2024?

Yes, if the content promotes your drugs. The Uniform Code for Pharmaceutical Marketing Practices 2024, issued by the Department of Pharmaceuticals on 12 March 2024, treats promotion as any informational or persuasive activity meant to induce prescription, supply, purchase or use of a drug, and a website product page can easily fall inside that.

The code is short and worth reading in full on the Department of Pharmaceuticals website. A few clauses shape website copy directly, and we build our pre-publish checklist around them:

• Clause 1.2: promotion must match the terms of marketing approval, and a drug must not be promoted before approval. Pipeline products need careful, non-promotional wording.
• Clause 2.2: “safe” must not be used without qualification, and you cannot say a medicine has no side effects.
• Clause 2.3: “new” cannot describe a drug generally available or promoted in India for more than a year.
• Clause 2.5: other companies' brand names are not used in comparisons without their prior consent.
• Clause 3.6: names or photographs of healthcare professionals must not appear in promotional material.
• Clause 3.8: where appropriate, the date of the last review is stated, so every product page carries one.

We are developers, not your regulatory team. We flag words and patterns that commonly cause trouble, and your medical or regulatory head signs off each page before it goes live. Compliance with the code stays your responsibility.

What must a product page for doctors show under UCPMP 2024?

When material is meant to help a prescriber decide, clause 3.2 of UCPMP 2024 lists minimum information that must be legible and part of the material itself. On a website, that means the gated product page carries these fields as a template, not as an optional note.

The fields are the name and address of the authorisation holder, the drug name with its active ingredients by generic name placed right next to the most prominent brand name, recommended dosage and method of use, adverse reactions, warnings, precautions and contraindications, and a statement that more information is available on request with the date the particulars were last updated. Building these as required fields in the CMS means nobody can publish a half-filled page by mistake.

Clause 6.2 also asks pharmaceutical companies to share details of CME and CPD events they conduct, including expenditure, on their website. We build a simple events-disclosure page your compliance team updates, with a table of event, date, organiser, location and spend. The code further asks the company's executive head to file an annual self-declaration within two months of the financial year end; some companies choose to publish it, and a documents page handles that easily.

None of this makes a website “UCPMP-approved”; no such stamp exists for a site. It simply makes the structure help your reviewers instead of fighting them.

Investor relations and CSR pages: what listed and larger pharma companies publish

If your shares are listed, Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 requires a functional website with a prescribed list of disclosures, and changes must be updated within two working days. If the CSR provisions of section 135 of the Companies Act, 2013 apply to you, the board places the CSR policy on the company's website, if it has one.

For a pharma company website design project, that translates into an investor section with a predictable structure: company overview and constitutional documents, board and committee composition, policies, financial results, shareholding pattern, annual reports, analyst and earnings-call material, credit ratings, and grievance contacts. Your company secretary and legal counsel own the list and its completeness; our job is to make the section easy to update and hard to break.

We build each disclosure type as a dated document list, newest first, with a year filter. Uploads are PDFs with sensible file names, so a shareholder searching in 2029 finds the 2026 annual report. The CSR area holds the policy, the committee composition and project summaries, plus plant-community stories if you want them, written without promotional claims about products.

Unlisted companies do not need all of this, but many still publish a short profile, quality policy and CSR summary because banks, large hospital buyers and export partners ask for them during due diligence.

How much does pharma company website design cost in India?

Pharma company website design starts at ₹10,000 for a catalogue site of up to 100 pages, ₹20,000 for a molecule-level site of 299 or more pages, and ₹60,000 for a distributor or doctor portal with logins. The final number depends on product count, gated areas, integrations and how much content you supply ready to publish.

The main cost drivers, in order of how much they usually move the quote:

• Number of products and variants: 60 products and 600 strength-pack combinations are very different builds.
• Gating: a declaration gate is small; a verified login with CME or sample requests is custom software.
• Integrations: CRM, ERP stock or price feeds, and WhatsApp alerts each add scope.
• Investor section: small if you upload PDFs, larger if results need tables and charts.
• Content: writing, reviewing and approving 300 product descriptions takes more time than coding them.
• Languages: Hindi, regional or export-market language versions, with translations you supply or approve.

Other freelancers and agencies quote across a wide range for pharma sites, mostly because of these same drivers and how much regulatory copy review they include. Compare what is itemised, not only the total. Our pricing page lists every starting price, and website making cost in India explains the general cost logic.

How long does a pharma website take, and what do you own at the end?

A catalogue site takes 1–2 weeks of build time, a molecule-level site 3–5 weeks, and a portal 6–12 weeks. In pharma the calendar is usually set by review, not development: product data and medical sign-off often take longer than the code.

Plan for this honestly. Your regulatory or medical head will want to read every product page, the quality head will check every certificate entry, and the company secretary will want the investor section right. We send pages for review in batches of twenty or thirty, so reviewers are never handed 400 pages on one Friday.

Ownership is simple: the domain, hosting account, code repository and CMS administrator logins are all in your company's name from the start. We work as invited users. At handover you get the repository, a short admin guide written for your team, and a list of every third-party service with its login owner. Two months of free maintenance follow launch; after that, upkeep starts at ₹8,000/mo if you want us to keep going, and you are free to take the site elsewhere. Details sit in your written quote and our terms.

What tech stack suits pharma company website design?

For most pharma companies, a fast static or hybrid site built with a modern framework, fed by a headless CMS or a simple structured product store, is the right choice. It is quick to load, hard to hack, and cheap to host, which matters for a site that mostly publishes documents and product records.

WordPress still suits companies whose marketing teams already know it, provided the theme is light, plugins are few and updates are someone's job. Where a portal is needed, we build it as a separate web app with its own login and database, rather than bolting logins onto a brochure site. Another of us handles AWS or other cloud setup, backups and access control; one of us builds the front end and product data model; the third of us runs the project plan and review batches.

SEO and AI search for a pharma company website: what helps and what to avoid

Molecule-level pages with clean URLs, generic names in titles, product schema, fast loading and honest trade content are what help a pharma site show up for distributors and importers. Consumer-facing claims that a drug cures a disease are what to avoid.

India's Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertisements for drugs that claim to treat the diseases listed in its schedule, among other categories, so a pharma site should not chase patient-intent keywords with cure claims. The better targets are trade queries: molecule plus “manufacturer”, “supplier”, “exporter”, “third party manufacturing” and dosage form. Those searchers are the people who buy.

For AI answer engines, the same structure helps. A page that states plainly which company makes a molecule, in which forms and strengths, at which certified site, is easy for an AI summary to quote. We set up Google Search Console, submit sitemaps, and write short factual answer blocks on key pages. Rankings are never guaranteed by anyone, including us. Ongoing work is covered by pharma SEO from ₹10,000/mo a month, and AI Overview optimisation explains how summaries pick sources.

Does a pharma website need consent on its enquiry and doctor forms?

Yes, plan for it. The Digital Personal Data Protection Act, 2023 governs personal data collected through your forms, and its rules, notified in November 2025, bring most notice and consent duties into force in phases through 2027. A pharma site collects more personal data than most: doctors' names and registration numbers, distributors' details, job applicants' CVs.

What the build does to support you: each form shows a short notice of what is collected and why, consent checkboxes are unticked by default, analytics and marketing cookies stay off until the visitor agrees, and form data is stored in one place with access limited to named staff. We keep only the fields you actually use; a distributor form does not need a date of birth. Deleting or exporting a person's record is a button in the admin, not a developer ticket.

We do not give legal advice or certify compliance. Your own counsel should review the privacy notice and retention periods. For a closer look at hardening, see website security.

Pharma company website design across India

We work remotely with pharma and life-science businesses in every state, so your plant location does not limit who builds your site. Calls happen on Google Meet or WhatsApp in English or Hindi, and documents move through shared folders.

India's pharma manufacturing sits in clusters, and each has a slightly different website need. Gujarat's formulators around Ahmedabad and Vadodara, and API and intermediate makers near Ankleshwar and Vapi, often lead with export capability. Bulk-drug and research businesses in Hyderabad and the pharma parks near Visakhapatnam lean on API catalogues and regulatory filings. Marketers and head offices in Mumbai and Pune care about investor and CSR sections, while the Himachal belt, served from Chandigarh, and units near Dehradun host many contract manufacturers who need capability pages more than brand pages. Indore and Aurangabad have growing formulation units, and Bengaluru adds biotech firms whose sites explain science to partners.

The site structure we recommend changes with that profile. The ideas on this page apply everywhere; the balance between catalogue, trade, export and investor content is what we tune for you.

Pharma company website design checklist before launch

Run this list with your quality, regulatory, sales and company secretary teams in one meeting a week before launch. Every “no” is a fix, not a debate.

• Every product page shows the generic name next to the brand, with strength and dosage form.
• Prescriber detail sits behind the healthcare-professional gate, and the gate works on phones.
• No page uses “safe” without qualification, and “new” only for products launched in India within the past year.
• No competitor brand names in comparisons without written consent; no doctor names or photos in promotional content.
• Each product and certificate entry shows a last-reviewed date.
• Every certificate has issuer, scope and valid-until date; expired ones are removed.
• Distributor and export forms route to the correct person and trigger an alert.
• Consent notices on all forms; non-essential cookies off until consent.
• Investor documents are complete, dated and downloadable, if you are listed.
• Domain, hosting, repository and CMS admin are in the company's name; backups tested.
• Search Console verified, sitemap submitted, pages load quickly on a mid-range Android phone.

Red flags when choosing a builder: they offer to register the domain in their own name, promise first-page rankings, or write product claims without asking who in your team approves them.

Worked example: planning pharma company website design for a mid-size formulator

Say a hypothetical formulations maker near Vadodara has 180 products across tablets, capsules and oral liquids, supplies distributors in eleven states, exports to a handful of African and South-East Asian markets, and is unlisted. Here is how we would plan it.

First, the audience map: public pages for the company, plant and quality story; a declaration gate for prescribing detail; a trade path for distributors; and an export path with dossier requests. No investor section beyond a profile and CSR summary, because the company is unlisted.

Second, the catalogue: 180 products with roughly 400 strength-pack combinations means the molecule-level plan from ₹20,000, because each combination deserves its own page for importers searching by molecule and form. The product records are loaded from the company's existing Excel master after a cleanup pass.

Third, forms: a two-step distributor form mapped to four zonal managers, and an export form feeding a shared sheet read by the export desk. WhatsApp alerts go to each manager. A portal is deferred until enquiries prove the need.

Fourth, review: pages go to the regulatory head in batches of 30, with the UCPMP checklist attached. Build time sits inside the 3–5 week range; review usually sets the real launch date. This is an illustration, not a past project, and your quote would reflect your own numbers.